Mynosys Cellular Devices Inc. is a medical device company providing innovative solutions to help surgeons achieve perfection in cataract surgery. Our product Zepto®, is a unique micro-fabricated instrument that provides unmatched precision during surgery on a millisecond time scale to tackle routine and challenging cases with confidence and efficiency. Zepto® technology is patented worldwide and is available in selected markets through local distributors.

NEWS

12 Jun Mynosys Announces Significantly Less Posterior Capsular Opacification in Patients After Zepto® Capsulotomy FREMONT, CALIF. (PRWEB) JUNE 06, 2018 Mynosys Cellular Devices ... read more ›
31 May Aequus Announces Official Launch of Zepto Capsulotomy System in Canada to be June 1, 2018 Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” ... read more ›
18 May ESCRS Lisbon 2017 David Chang Interview about Zepto with TheOphthalmologist Dr. David Chang Discusses Zepto Capsulotomy System for Cataract ... read more ›

FEATURED VIDEO